α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)
Methoxamine (Mox) is a well-known α1-adrenoceptor agonist, clinically used as a longer-acting analogue of epinephrine. 1R,2S-Mox (NRL001) has been also undergoing clinical testing to increase the canal resting pressure in patients with bowel incontinence. Here we show, that Mox hydrochloride acts as...
Saved in:
Main Authors: | Kohutova Aneta, Münzova Dita, Pešl Martin, Rotrekl Vladimir |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2023-0012 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apurinic/apyrimidinic endonuclease 1 alleviates inflammation in fibroblast-like synoviocytes from patients with rheumatoid arthritis
by: Ha-Reum Lee, et al.
Published: (2024-08-01) -
Pancreas Proapoptotic Proteases in Patients with Chronic Pancreatitis
by: N. B. Gubegritz, et al.
Published: (2019-06-01) -
An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder
by: Zhipeng Zhang, et al.
Published: (2025-01-01) -
Intrathecal Clonidine versus Dexmedetomidine as Adjuvants to Hyperbaric Ropivacaine in Lower Limb Orthopaedic Surgeries: A Randomised Clinical Study
by: Priya Kishnani, et al.
Published: (2025-02-01) -
Efficacy of 5 µg and 10 µg Dexmedetomidine as Adjuvants to 3 mL 0.5% Hyperbaric Bupivacaine in Pelvic and Lower Limb Orthopaedic Surgeries: A Randomised Clinical Study
by: Jigisha Bharatbhai Mehta, et al.
Published: (2025-02-01)